Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression

Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression

Background Programmed death-ligand 1 (PD-L1), a transmembrane protein, binds to the programmed death-1 (PD-1) receptor, and anti-PD-1 therapy enables immune responses against tumors. This study aimed to assess clinical characteristics of PD-L1 expression using immunohistochemistry among Korean pati...

Full description

Bibliographic Details
Main Authors: Ha-Young Park, M.D., In-Jae Oh, M.D., Ph.D., Bo Gun Kho, M.D., Tae-Ok Kim, M.D., Hong-Joon Shin, M.D., Cheol Kyu Park, M.D., Ph.D., Yong-Soo Kwon, M.D., Ph.D., Yu-Il Kim, M.D., Ph.D., Sung-Chul Lim, M.D., Ph.D., Young-Chul Kim, M.D., Ph.D., Yoo-Duk Choi, M.D., Ph.D.
Format: Article
Language:English
Published: The Korean Academy of Tuberculosis and Respiratory Diseases 2019-07-01
Series:Tuberculosis and Respiratory Diseases
Subjects:
asian continental ancestry group
patients
lung neoplasms
gene expression
carcinoma
non-small-cell lung
Online Access:https://www.e-trd.org/search.php?where=aview&id=10.4046/trd.2018.0070&code=0003TRD&vmode=FULL

Internet

https://www.e-trd.org/search.php?where=aview&id=10.4046/trd.2018.0070&code=0003TRD&vmode=FULL

Similar Items